Synth-Med Biotechnology
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Mars Centre West Twr, 661 University Ave...Website
www.synth-med.comRevenue
<$5 MillionIndustry
About Synth-Med Biotechnology
Synth-Med Biotechnology is an early-stage company focused on revolutionizing drug delivery systems by utilizing the unique properties of red blood cells for targeted therapeutic delivery. Their platform enables the delivery of various therapeutic modalities, with a lead asset aimed at enhancing memory in Alzheimer's disease. The company is led by a multidisciplinary team with expertise in drug development, pharmacology, and biophysics, and is actively expanding its pipeline to address additional disease areas. Synth-Med is currently seeking to grow its team with new laboratory technicians.Explore more
Synth-Med Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Synth-Med Biotechnology
Compare insights from companies similar to Synth-Med Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Synth-Med Biotechnology Tech Stack
A closer look at the technologies used by Synth-Med Biotechnology
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Synth-Med Biotechnology
Sign Up For FreeTo access detailed company insights
Synth-Med Biotechnology is an early-stage company focused on revolutionizing drug delivery systems by utilizing the unique properties of red blood cells for targeted therapeutic delivery. Their platform enables the delivery of various therapeutic modalities, with a lead asset aimed at enhancing memory in Alzheimer's disease. The company is led by a... Read More
